These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23576221)

  • 1. Partition testing in confirmatory adaptive designs with structured objectives.
    Sugitani T; Hamasaki T; Hamada C
    Biom J; 2013 May; 55(3):341-59. PubMed ID: 23576221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On sample size determination in multi-armed confirmatory adaptive designs.
    Wassmer G
    J Biopharm Stat; 2011 Jul; 21(4):802-17. PubMed ID: 21516570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An adaptive confirmatory trial with interim treatment selection: practical experiences and unbalanced randomization.
    Heritier S; Lô SN; Morgan CC
    Stat Med; 2011 Jun; 30(13):1541-54. PubMed ID: 21432887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive designs for confirmatory clinical trials.
    Bretz F; Koenig F; Brannath W; Glimm E; Posch M
    Stat Med; 2009 Apr; 28(8):1181-217. PubMed ID: 19206095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive methods: when and how should they be used in clinical trials?
    Porcher R; Lecocq B; Vray M;
    Therapie; 2011; 66(4):319-26, 309-17. PubMed ID: 21851793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I error rate control in adaptive designs for confirmatory clinical trials with treatment selection at interim.
    Posch M; Maurer W; Bretz F
    Pharm Stat; 2011; 10(2):96-104. PubMed ID: 22328314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A graphical approach to sequentially rejective multiple test procedures.
    Bretz F; Maurer W; Brannath W; Posch M
    Stat Med; 2009 Feb; 28(4):586-604. PubMed ID: 19051220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bonferroni-based correction factor for multiple, correlated endpoints.
    Shi Q; Pavey ES; Carter RE
    Pharm Stat; 2012; 11(4):300-9. PubMed ID: 22588983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some challenges with statistical inference in adaptive designs.
    Hung HM; Wang SJ; Yang P
    J Biopharm Stat; 2014; 24(5):1059-72. PubMed ID: 24915027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of adaptive designs: efficiency evaluation.
    Menon S; Chang M
    J Biopharm Stat; 2012; 22(4):641-61. PubMed ID: 22651106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innovative approaches for designing and analyzing adaptive dose-ranging trials.
    Bornkamp B; Bretz F; Dmitrienko A; Enas G; Gaydos B; Hsu CH; König F; Krams M; Liu Q; Neuenschwander B; Parke T; Pinheiro J; Roy A; Sax R; Shen F
    J Biopharm Stat; 2007; 17(6):965-95. PubMed ID: 18027208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptive Dunnett tests for treatment selection.
    Koenig F; Brannath W; Bretz F; Posch M
    Stat Med; 2008 May; 27(10):1612-25. PubMed ID: 17876763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flexible two-stage design with sample size reassessment for survival trials.
    Desseaux K; Porcher R
    Stat Med; 2007 Nov; 26(27):5002-13. PubMed ID: 17577242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new partition testing strategy for multiple endpoints.
    Wang B; Cui X
    Stat Med; 2012 Sep; 31(20):2151-68. PubMed ID: 22532094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accurate p-values for adaptive designs with binary endpoints.
    Heritier S; Lloyd CJ; Lô SN
    Stat Med; 2017 Jul; 36(17):2643-2655. PubMed ID: 28470713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptive seamless designs: selection and prospective testing of hypotheses.
    Jennison C; Turnbull BW
    J Biopharm Stat; 2007; 17(6):1135-61. PubMed ID: 18027222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive design in clinical research: issues, opportunities, and recommendations.
    Chang M; Chow SC; Pong A
    J Biopharm Stat; 2006 May; 16(3):299-309; discussion 311-2. PubMed ID: 16724486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dual test: safeguarding p-value combination tests for adaptive designs.
    Burman CF; Lisovskaja V
    Stat Med; 2010 Mar; 29(7-8):797-807. PubMed ID: 20213723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sample size re-estimation for survival data in clinical trials with an adaptive design.
    Togo K; Iwasaki M
    Pharm Stat; 2011; 10(4):325-31. PubMed ID: 22328325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical challenges in a regulatory review of cardiovascular and CNS clinical trials.
    Hung HM; Wang SJ; Yang P; Jin K; Lawrence J; Kordzakhia G; Massie T
    J Biopharm Stat; 2016; 26(1):37-43. PubMed ID: 26366624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.